Delivery Order SPE2DB20D3103-SPE2DB24FP4Y0

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,528,749 units of the medication clobazam 10 mg tablets, with a ceiling value of $1,555.93. The contract has an ultimate completion date of November 25, 2024, and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,882.91 fixed-price delivery order is for the supply of 4,566,910 units of the drug Clobazam 10 mg tablets. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,853.88, is for the supply of 4,566,719,361 units of the generic drug Clobazam 10 mg tablets. The contract has a completion date of December 16, 2024 and is a firm fixed-price type. It was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 tablets of the medication Clobazam 10 mg. The contract has a firm fixed price of $3,111.86 and a completion date of June 6, 2025. The award is not set-aside and was made on June 5, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,249,033 units of the prescription medication clobazam 10 mg tablets. The contract has a firm fixed price of $4,829.56 and a completion date of May 15, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,053.33 firm fixed-price delivery order is for the supply of 4,567,363,282 units of the pharmaceutical drug Clobazam 10 mg tablets. The contract has an ultimate completion date of February 25, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,619.69, is for the delivery of 4,567,887,267 tablets of the drug clobazam 10 mg. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 14, 2025. The contract was awarded on April 11, 2025 and does not have a set-aside designation. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,157.36 award is for the delivery of 4,565,166,084 units of clobazam 10 mg tablets. The contract has a firm fixed price and a completion date of July 17, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,401.14 firm fixed-price delivery order covers the supply of 4,566,554,838 units of the medication clobazam 10 mg tablets. The contract has a period of performance through November 27, 2024 and was not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,935.11 firm fixed-price contract is for the supply of 4,563,131,211 units of the medication clobazam 10 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP4Y0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,111.86 firm fixed-price contract is for the delivery of 4,565,120 units of the prescription drug Clobazam 10 mg tablets. The contract has an ultimate completion date of July 12, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:42 AM